Genome-wide studies showed that subjects carrying a TREM2 polymorphism that impairs receptor functioning have a risk of developing AD, to an extent even similar to the one related to APOE-E4 allele (which had been considered by far as the most relevant AD risk factor) [80]. Here, APOE is linked to Alzheimer disease.